re.Mind Capital

Investor type Venture Capital

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 13
Average round size
info
The average size of a deal this fund participated in
$47M
Portfolio companies 11
Rounds per year 6.50
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.15
Key employees Soon

Areas of investment

  • Biotechnology
  • Neuroscience
  • Health Care
  • Software
  • Medical

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of re.Mind Capital:
Typical Co-investors
re.Mind Capital is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after re.Mind Capital:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Aeternam Stella China, Shanghai
Collective Capital England, London, United Kingdom
Framestore England, London, United Kingdom
Global Insurance Accelerator Des Moines, Iowa, United States
Granite State Angels Hanover, New Hampshire, United States
Hyundai Heavy Industries Holdings Daejeon, South Korea, Taejon-jikhalsi
I-Source Gestion France, Ile-de-France, Paris
KIDS HOLDINGS Japan, Tokyo
Kxter Fund One California, San Francisco, United States
Mariner Partners Canada, New Brunswick, Saint John
Merrill Lynch Investment Managers New Jersey, Princeton, United States
Rimonim Fund Israel, South Dakota, United States
Schwan's Shared Services,LLC Marshall, Minnesota, United States
Sella Ventures -
Shanghai Shixi China, Jinshan District
The Andan Foundation Obwalden, Sarnen, Switzerland
Vidinovo -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Alena

Health Care
mHealth
Software
Wellness
$2M23 Mar 2022 London, England, United Kingdom

OccamzRazor

Artificial Intelligence
Machine Learning
Neuroscience
$6M08 Mar 2022 San Francisco, California, United States

CereGate

Medical Device
Software
12 Jan 2022 Munich, Bavaria, Germany

OpenBCI

Electronics
Hardware
Open Source
Software
15 Dec 2021 Brooklyn, New York, United States

Neumora Therapeutics

Biotechnology
Health Care
Medical
$400M07 Oct 2021 Watertown, Massachusetts, United States

Delix Therapeutics

Biotechnology
$70M27 Sep 2021 Boston, Massachusetts, United States

TRIPP

Computer
Developer Platform
Gaming
$11M25 Jun 2021 Los Angeles, California, United States

Ksana Health

Apps
Health Care
Medical
$2M16 Jun 2021 Eugene, Oregon, United States

Synchron

Information Technology
Manufacturing
Marketing
Medical Device
$40M03 Jun 2021 California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent re.Mind Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: